fibrinogen has been researched along with Placenta, Retained in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, HM | 1 |
| Annecke, T; Geisenberger, T; Heindl, B; Kürzl, R; Penning, R | 1 |
1 review(s) available for fibrinogen and Placenta, Retained
| Article | Year |
|---|---|
Aetiology and treatment of severe postpartum haemorrhage.
Topics: Erythrocyte Transfusion; Female; Fibrinogen; Hemostatics; Humans; Hysterectomy; Oxytocics; Oxytocin; Placenta, Retained; Postpartum Hemorrhage; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors | 2018 |
1 other study(ies) available for fibrinogen and Placenta, Retained
| Article | Year |
|---|---|
Algorithm-based coagulation management of catastrophic amniotic fluid embolism.
Topics: Acidosis; Adult; Algorithms; Blood Coagulation Factors; Blood Component Transfusion; Cardiovascular Agents; Case Management; Catastrophic Illness; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Embolism, Amniotic Fluid; Fatal Outcome; Female; Fibrinogen; Humans; Hypotension; Hysterectomy; Infant, Newborn; Male; Multiple Organ Failure; Placenta, Retained; Postpartum Hemorrhage; Pregnancy; Sperm Injections, Intracytoplasmic; Thrombelastography; Tranexamic Acid | 2010 |